Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leighton E Clancy

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Blood Advances|July 30, 2020
Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activityGloria Castellano-González, Helen M McGuire, Fabio Luciani, et al.
Blood Advances|January 4, 2018
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cellsBarbara Withers, Emily Blyth, Leighton E Clancy, et al.
Blood Advances|July 12, 2022
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplantWei Jiang, Leighton E Clancy, Selmir Avdic, et al.
Blood|May 11, 2021
Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cellsKenneth P Micklethwaite, Kavitha Gowrishankar, Brian S Gloss, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Blood Advances|July 30, 2020
Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activityGloria Castellano-González, Helen M McGuire, Fabio Luciani, et al.
Blood Advances|January 4, 2018
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cellsBarbara Withers, Emily Blyth, Leighton E Clancy, et al.
Blood Advances|July 12, 2022
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplantWei Jiang, Leighton E Clancy, Selmir Avdic, et al.
Blood|May 11, 2021
Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cellsKenneth P Micklethwaite, Kavitha Gowrishankar, Brian S Gloss, et al.
Pageof 2